Peter A. Lio, MD, clinical assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine, gives a preview of his session on mild to moderate atopic dermatitis (AD) in skin of color.
Peter A. Lio, MD, clinical assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine, talks about some of the topics he will be discussing during his session to be presented at the 2023 Fall Clinical Dermatology Conference, which takes place October 19-22, 2023, both in-person and virtually. This session will delve into the variations in atopic dermatitis (AD) among patients with diverse skin tones globally, address potential differences in treatments, and emphasize the crucial need for a comprehensive understanding of these distinctions so that each patient can get the care they need, explained
Transcript
What are some topics you’ll be highlighting in your session on mild to moderate AD in skin of color?
There has been an incredible revolution, finally, after a very long drought and a long delay, we are understanding more than we've ever understood before about atopic dermatitis. I call this the virtuous cycle of drug development. We get new treatments that actually treat the condition better, and then that not only helps those patients directly—which is great, we need new treatments, of course—but it also informs us about the disease itself. We learn more about it, which then in turn gives us better treatments. We're in this process of refinement, and one of the areas we realized has been, and I think we're realizing this as the society overall but it's been really underreported [and] understudied, is looking at skin of color, because we know there are some important differences that have been unaddressed. Finally, I think we're starting to see how we're able to learn more about it, to pay better attention to it, and of course to bring better treatments so those patients can do great as well. We want to make sure everybody is well taken care of.
In this session, we're going to explore some of the reasons why maybe we have some differences between atopic dermatitis in patients with darker skin types and those with lighter skin types and regionally around the globe, what this means, why some of those treatments might be a little bit different, and also discussing why it's so important that we understand those differences, because I think no matter where you practice, we're still going to see patients that span the range. Some areas are certainly more diverse than others, but I think everybody wants to be in a good place so that they can take care of whatever comes through that door. And the world is increasingly global, so I think we all understand that it's our job and, honestly, it's a pleasure to try to understand and take good care of every individual patient, and to do that we need some more tools in our toolbox.
Who is your target audience for this session?
We're talking to a wide range of practitioners. Dermatologists of course are, in some ways, the main thrust, but there are many nurse practitioners and physician assistants who are taking tremendously great care of patients and are very much involved. Of course, there are even practitioners who are nonspecialized in dermatology, maybe pediatricians and primary care physicians, they are seeing a lot of skin problems. Try as we might, we're only a small group of physicians across this larger landscape of people who are required to help us take the best care of our patients. We literally can't see everybody, so we want everyone to be informed. I think anybody taking care of skin problems, in particular atopic dermatitis, I think they're going to learn something and bring home some new ideas.
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
The IRA’s Unintended Consequences for Drug Pricing and Coverage
April 2nd 2025The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling pharmaceutical innovation, experts warned at the Academy of Managed Care Pharmacy 2025 annual meeting.
Read More